Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations.
Harari
Paul M
PM
Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA.
Ritter
Mark A
MA
Petereit
Daniel G
DG
Mehta
Minesh P
MP
D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects / Q000379:methods; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy / Q000379:methods; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D019317:Evidence-Based Medicine; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D010358:Patient Participation; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant / Q000379:methods; D016032:Randomized Controlled Trials as Topic